HIV-1-Based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

HIV-1-Based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

A prophylactic vaccine eliciting both broad neutralizing antibodies (bNAbs) to the HIV-1 envelope glycoprotein (Env) and strong T cell responses would be optimal for preventing HIV-1 transmissions. Replication incompetent HIV-1 virus-like particles (VLPs) offer the opportunity to present authentic-s...

Full description

Bibliographic Details
Main Authors:	Christopher A. Gonelli, Georges Khoury, Rob J. Center, Damian F.J. Purcell
Format:	Article
Language:	English
Published:	MDPI AG 2019-06-01
Series:	Viruses
Subjects:	HIV-1 virus-like particle VLP mature-form particle assembly
Online Access:	https://www.mdpi.com/1999-4915/11/6/507

Similar Items

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
by: Christopher A. Gonelli, et al.
Published: (2021-03-01)

Morphogenesis of the infectious HIV-1 virion
by: Jun-Ichi eSakuragi
Published: (2011-12-01)

HIV-1 Maturation: Lessons Learned from Inhibitors
by: Alex B. Kleinpeter, et al.
Published: (2020-08-01)

In Vitro Assembly of Virus-Like Particles and Their Applications
by: Dinh To Le, et al.
Published: (2021-04-01)

Nanocontainer designed from an infectious hypodermal and hematopoietic necrosis virus (IHHNV) has excellent physical stability and ability to deliver shrimp tissues
by: Pauline Kiatmetha, et al.
Published: (2018-12-01)

RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021-08-01)

FRET-Based Detection and Quantification of HIV-1 Virion Maturation
by: Anamaria D. Sarca, et al.
Published: (2021-03-01)

FRET-based detection and quantification of HIV-1 Virion Maturation
by: Sarca, Anamaria Daniela
Published: (2021)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
by: Minna M. Hankaniemi, et al.
Published: (2020-08-01)

Consistent Fabrication of Ultrasmall PLGA Nanoparticles and their Potential Biomedical Applications
by: Lohneis, Taylor Paige
Published: (2019)

A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model
by: Velasco Cimica, et al.
Published: (2021-05-01)

Virion stiffness regulates immature HIV-1 entry
by: Pang Hong-Bo, et al.
Published: (2013-01-01)

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity
by: Zhao Qinjian, et al.
Published: (2012-02-01)

Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1
by: Nikole L. Warner, et al.
Published: (2021-07-01)

Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation
by: Mariia Novikova, et al.
Published: (2018-10-01)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
by: Mitch Brinkkemper, et al.
Published: (2019-07-01)

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
by: Daria A. Rutkowska, et al.
Published: (2019-12-01)

Soil Viral Communities Vary Temporally and along a Land Use Transect as Revealed by Virus-Like Particle Counting and a Modified Community Fingerprinting Approach (fRAPD)
by: Anja Narr, et al.
Published: (2017-10-01)

Potent programmable antiviral against dengue virus in primary human cells by Cas13b RNP with short spacer and delivery by VLP
by: Ekapot Singsuksawat, et al.
Published: (2021-06-01)

Computational Study of Post Translation Modification in Chimeric Virus Like Particles Vaccine of Human Papilloma Virus with Virion Capsid L1
by: Arli Aditya Parikesit, et al.
Published: (2007-11-01)

Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
by: Jennifer L Elliott, et al.
Published: (2020-09-01)

Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles
by: Purcell Damian FJ, et al.
Published: (2011-08-01)

Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis
by: Jennifer L. Elliott, et al.
Published: (2020-09-01)

Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing
by: Pin Lyu, et al.
Published: (2020-12-01)

Unveiling the Hidden Rules of Spherical Viruses Using Point Arrays
by: David P. Wilson
Published: (2020-04-01)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
by: Gustavo Cabral-Miranda, et al.
Published: (2017-05-01)

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
by: Jens Schumacher, et al.
Published: (2018-04-01)

Hepatitis B core-based virus-like particles: A platform for vaccine development in plants
by: Maryam Moradi Vahdat, et al.
Published: (2021-03-01)

Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
by: Peng Xiao, et al.
Published: (2021-02-01)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
by: Rosamund Chapman, et al.
Published: (2020-01-01)

CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses
by: Phoebe E. Lewis, et al.
Published: (2020-06-01)

Virus like particles as a platform for cancer vaccine development
by: Hui Kian Ong, et al.
Published: (2017-11-01)

Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice
by: Shu C, et al.
Published: (2020-03-01)

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
by: Stefan W. Metz, et al.
Published: (2018-04-01)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
by: Gustavo Cabral-Miranda, et al.
Published: (2018-11-01)

From Crescent to Mature Virion: Vaccinia Virus Assembly and Maturation
by: Liang Liu, et al.
Published: (2014-10-01)

Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
by: Zoltan Beck, et al.
Published: (2009-01-01)

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
by: Mona O. Mohsen, et al.
Published: (2019-04-01)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
by: Mona O. Mohsen, et al.
Published: (2018-07-01)

Self-assembling protein nanoparticles in the design of vaccines
by: Jacinto López-Sagaseta, et al.
Published: (2016-01-01)